Evidence map›Paper›PMID 33218209›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Potential Inhibitory Effect of

Hala Nehme, Helena Ayde, Dany El Obeid, Jean Marc Sabatier, Ziad Fajloun

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Effect ofMolecules (Basel, Switzerland) · 2024
    Article
  7. Antimicrobial Activity ofAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Inhibitors of ATP Synthase as New Antibacterial Candidates.Antibiotics (Basel, Switzerland) · 2023
    Review
  9. Molecules (Basel, Switzerland) · 2022
    Article
  10. Review
  11. The Cytotoxic Effect ofMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hala NehmeBioactive Molecules Research Laboratory, Faculty of Sciences, Section II, Lebanese University, B.P. 90656, Jdeidet El-Matn 1202, Lebanon.
Helena AydeBioactive Molecules Research Laboratory, Faculty of Sciences, Section II, Lebanese University, B.P. 90656, Jdeidet El-Matn 1202, Lebanon.
Dany El ObeidFaculty of Agriculture & Veterinary Sciences, Lebanese University, Dekwaneh, Beirut 2832, Lebanon.
Jean Marc SabatierInstitut de Neuro-Physiopathologie, Faculté de Médecine Secteur Nord 51, Université Aix-Marseille, UMR 7051, Boulevard Pierre Dramard-CS80011, 13344-Marseille CEDEX 15, France.ORCID 0000-0002-9040-5647
Ziad FajlounLaboratoire de Biotechnologie Appliquée (LBA3B), Centre Azm pour la Recherche en Biotechnologie et ses Applications, EDST, Lebanese University, Tripoli 1300, Lebanon.ORCID 0000-0002-6502-3110
Lebanese University · LBInstitut de Neurophysiopathologie · FR

Funding

Université Libanaise This research was funded by the Research Funding Program at the Lebanese University (2018-2020)
6 · The paper itself

Abstract

Bacterial resistance has become a worrying problem for human health, especially since certain bacterial strains of

Indexed as

antibacterial activityantibiotic resistanceApis mellifera bee venomEscherichia coliF1F0-ATPaseinhibitory assays

Identifiers

PMID33218209
PMCPMC7699247
OpenAlexW3099639977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.